FIELD: medicine, pharmacy.
SUBSTANCE: invention describes a medicament comprising separately or as the unit composition (A) a compound of the formula (I) given in the invention description as a free form or a pharmaceutically acceptable salt or solvate, and (B) corticosteroid designated for simultaneous, successive or separate administration in treatment of inflammatory or obstructive diseases of respiratory ways wherein the molar ratio of component (A) to (B) is from 100:1 to 1:300. Proposed medicaments possess high broncholytic and anti-inflammatory properties and used in treatment of inflammatory or obstructive diseases of respiratory ways.
EFFECT: improved and valuable medicinal properties of agent.
17 cl, 245 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICINAL AGENT AND PHARMACEUTICAL SET DESIGNATED FOR ASTHMA TREATMENT | 2000 |
|
RU2270670C2 |
| COMPOSITIONS COMPRISING FORMOTEROL AND THIOTROPIUM SALT | 2000 |
|
RU2238085C2 |
| COMPOSITIONS INCLUDING FORMOTEROL AND FLUCTICASON PROPIONATE INDICATED FOR TREATING ASTHMA | 2000 |
|
RU2249454C2 |
| INHALATION MEDICINES CONTAINING BETA-MEMETICS AND ANTICHOLINERGIC AGENT | 2004 |
|
RU2375059C2 |
| COMBINATIONS OF GLUCOPYRROLATE AND B-2 ADRENOCEPTOR ANTOGONISTS | 2005 |
|
RU2388465C2 |
| NEW DRUG COMBINATIONS FOR TREATING RESPIRATORY DISEASES | 2006 |
|
RU2436578C2 |
| NEW DOSE AND FORMULATION | 2009 |
|
RU2608713C2 |
| COMBINATIONS CONTAINING ANTI-MUSCARINE PREPARATIONS AND BETA-ADRENERGIC AGONISTS | 2005 |
|
RU2379033C2 |
| APPLICATION OF TIOTROPIUM SALTS FOR TREATMENT OF SEVERE FORMS OF PERSISTENT ASTHMA | 2006 |
|
RU2422144C2 |
| COMBINATION AND PHARMACEUTICAL PREPARATION FOR TREATING INFLAMMATORY AND OBSTRUCTIVE RESPIRATORY DISEASES | 2005 |
|
RU2438660C2 |
